We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

While presenting the data at this year's American Society of Clinical Oncology (ASCO) annual meeting, Peter Voorhees, MD, of ...

For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...

A GLP-1 medication used to treat type 2 diabetes and obesity may help cut a person's monthly migraine days by about half, a ...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

Recent studies indicate that GLP-1 receptor agonists medications such as liraglutide, widely prescribed for the treatment of ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with ...

Endovascular treatment of intracranial aneurysms (IAs) has evolved considerably over the past decades. The technological advances have been driven by the experience that coils fail to completely ...

GLP-1 agonists have gained recent widespread attention, reshaping treatment approaches for several diseases, including diabetes and cardiovascular disease. 2 In the treatment of type 2 diabetes, ...